Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1138.6000 13.80 (1.23%)
NSE Jul 14, 2025 15:58 PM
Volume: 819.9K
 

logo
Aurobindo Pharma Ltd.
13 Mar 2019, 12:00AM
1138.60
1.23%
Angel Broking
Aurobindo Pharmaceuticals (APL) has a big relief in form of Establishment Inspection report (EIR) for Unit-4 facility in which the USFDA has closed issued Form 483. The Form 483 is issued to a firms management at the conclusion of an inspection when an investigator(s) has observed any conditions that may constitute violations of the Food
Geojit BNP Paribas decreased Buy price target of Aurobindo Pharma Ltd. to 1348.0 on 04 Jul, 2025.
More from Aurobindo Pharma Ltd.
Recommended